Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine
SARS-CoV-2의 뉴클레오캡시드 단백질은 차세대 백신 개발을 위한 잠재적인 표적입니다
Article
Published on
Journal: Journal of Clinical Laboratory Analysis
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료법,
Journal: Journal of Clinical Laboratory Analysis
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료법,
[키워드] antibody
BALB/c mice
Blot
correlated
COVID-19 patient
COVID-19 patients
cytokine
cytokine production
develop
disease severity
elicited
ELISA
ELISA assay
ELISA assays
Escherichia coli
expressed
IgG antibody
IgM antibody
immune
immune response
immune responses
immunization
immunize
immunized
immunoreactivity
in viral
Infection
investigated
less
mice
mutations
N protein
nucleocapsid
nucleocapsid protein
potentiality
Prevent
produced
Protein
purified
S protein
SARS-CoV-2
SARS-CoV-2 N
SARS-CoV-2 N protein
SARS-CoV-2 variants
SARS-CoV-2 virus
serum
serum antibodies
serum antibody
specific serum
spike glycoprotein
Spread
the N protein
the S protein
the SARS-CoV-2
Vaccine
vaccine.
Vaccines
variants
Viral
viral infection
virus infection
virus infections
was used
were used
western blot
[DOI] 10.1002/jcla.24479 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/jcla.24479 PMC 바로가기 [Article Type] Article